Dr. Silberzweig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
505 E 70th St
2nd Floor
New York, NY 10021Phone+1 212-746-1562Fax+1 212-746-8439- Is this information wrong?
Summary
- Dr. Jeffrey Silberzweig is a nephrologist in New York, NY and is affiliated with multiple hospitals in the area, including NewYork-Presbyterian/Weill Cornell and NewYork-Presbyterian/Lower Manhattan Hospital. He received his medical degree from University at Buffalo, School of Medicine and Biomedical Sciences and has been in practice 28 years. He is currently the Chief Medical Officer of The Rogosin Institute and has extensive experience in general nephrology and dialysis.
Education & Training
University of Pennsylvania Health SystemFellowship, Nephrology, 1992 - 1994
Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Internal Medicine, 1989 - 1992
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1989
Certifications & Licensure
NY State Medical License 1991 - 2024
FL State Medical License 2012 - 2019
PA State Medical License 1991 - 1996- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Clinical Trials
- Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis Start of enrollment: 2015 Oct 01
- Procalcitonin and Brain Natriuretic Peptides in Patients With Chronic Kidney Disease. Start of enrollment: 2018 Dec 26
- Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial Start of enrollment: 2024 Sep 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Reducing Infections in Outpatient Hemodialysis: The Impact of Human Factors.Jeffrey I Silberzweig> ;American Journal of Kidney Diseases. 2024 Apr 11
- Management of Patients with Multidrug-Resistant Organisms in Outpatient Dialysis Facilities.Dittrich, M., Hymes, J., Giullian, J., Wong, L., Freedman, B., Bhat, J., Spry, L., Taylor, R., Spech, R., Silberzweig, J., Green, G., Durvasula, R., Blue, S.> ;Clinical Journal of the American Society of Nephrology. 2023 Dec 27
- Approaches to Maximize Safety for Patients with Kidney Diseases after the End of COVID-19 Public Health Emergency.Jeffrey Silberzweig, Alan S Kliger, David Lee White, Susan Stark, Vineeta Kumar> ;Clinical Journal of the American Society of Nephrology. 2023 Aug 29
- Join now to see all
Press Mentions
Q&A: Nephrologists Offer Next Steps in Addressing the COVID-19 Omicron VariantDecember 27th, 2021- Fauci, ASN Panelists Encourage Patients with CKD to Get COVID-19 Booster VaccineNovember 4th, 2021
- Expert COVID-19 Content on Open Access as Delta SurgesSeptember 7th, 2021
- Join now to see all
Hospital Affiliations
NewYork-Presbyterian/Lower Manhattan HospitalNew York, New York
NYC Health + Hospitals / QueensJamaica, New York
New York-Presbyterian HospitalNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
